1. Home
  2. FOLD vs KAI Comparison

FOLD vs KAI Comparison

Compare FOLD & KAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$14.19

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Logo Kadant Inc

KAI

Kadant Inc

HOLD

Current Price

$289.02

Market Cap

3.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOLD
KAI
Founded
2002
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.4B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
FOLD
KAI
Price
$14.19
$289.02
Analyst Decision
Buy
Buy
Analyst Count
8
2
Target Price
$29.79
$340.00
AVG Volume (30 Days)
14.8M
168.7K
Earning Date
11-04-2025
10-28-2025
Dividend Yield
N/A
0.47%
EPS Growth
N/A
N/A
EPS
N/A
8.65
Revenue
$598,704,000.00
$1,024,074,000.00
Revenue This Year
$21.49
N/A
Revenue Next Year
$18.25
$10.56
P/E Ratio
N/A
$33.40
Revenue Growth
21.28
N/A
52 Week Low
$5.51
$244.87
52 Week High
$14.36
$409.73

Technical Indicators

Market Signals
Indicator
FOLD
KAI
Relative Strength Index (RSI) 91.10 54.99
Support Level $10.64 $286.02
Resistance Level $11.14 $299.83
Average True Range (ATR) 0.36 9.28
MACD 0.28 0.92
Stochastic Oscillator 96.46 54.67

Price Performance

Historical Comparison
FOLD
KAI

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

About KAI Kadant Inc

Kadant Inc. supplies process and engineering equipment for papermaking, recycling, lumber manufacturing, and related industries. The company's three reportable segments are the Flow Control segment which consists of the fluid-handling and doctoring, cleaning, & filtration product lines; the Industrial Processing segment which consists of the wood processing and stock-preparation product lines; and Material handling systems, which provides conveyor-belt equipment for industries such as mining, food processing, and packaging. The company has a geographic presence in the U.S., China, Asia, Germany, Canada, and Others.

Share on Social Networks: